Literature DB >> 30405749

Effects of let-7c on the proliferation of ovarian carcinoma cells by targeted regulation of CDC25a gene expression.

Wei Zhang1, Qingru Zeng2, Zhenying Ban1, Jing Cao1, Tianjiao Chu1, Dongmei Lei1, Chi Liu3, Wentao Guo4, Xianxu Zeng1.   

Abstract

MicroRNAs serve a role in the development of ovarian cancer (OC). The present study investigated whether let-7c is able to regulate the proliferation of OC cells by targeting cell division cycle 25A (CDC25a). The reverse transcription-quantitative polymerase chain reaction was performed to detect the expression of let-7c in OC specimens. Let-7c agomir was transfected into OC cells, and the proliferation and apoptosis of OC cells were detected. A dual-luciferase assay and western blotting were performed to analyze whether CDC25a was the target gene of let-7c as well as its interaction site. The results revealed that, in OC tissue, let-7c was downregulated when compared with normal ovarian tissue. A Cell Counting Kit-8 (CCK8) assay, colony formation assay and flow cytometry demonstrated that increased expression of let-7c was able to inhibit the proliferation and increase the apoptosis of OC cells. Western blotting revealed that upregulated let-7c is able to decrease the expression of CDC25a, and a dual-luciferase assay and a recovery assay demonstrated that let-7c was able to regulate the expression of the 3' untranslated region of CDC25a. Therefore, the roles of let-7c in inhibiting the proliferation and promoting the apoptosis of OC cells may be realized through the regulation of the expression of CDC25a. The results of the present study revealed that let-7c may be a novel target in the diagnosis and treatment of OC.

Entities:  

Keywords:  cell division cycle 25a; let-7c; ovarian cancer; proliferation

Year:  2018        PMID: 30405749      PMCID: PMC6202515          DOI: 10.3892/ol.2018.9327

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  41 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Dual mode of degradation of Cdc25 A phosphatase.

Authors:  Maddalena Donzelli; Massimo Squatrito; Dvora Ganoth; Avram Hershko; Michele Pagano; Giulio F Draetta
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

3.  Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner.

Authors:  Dipankar Ray; Yasuhisa Terao; Dipali Nimbalkar; Li-Hao Chu; Maddalena Donzelli; Tateki Tsutsui; Xianghong Zou; Asish K Ghosh; John Varga; Giulio F Draetta; Hiroaki Kiyokawa
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

4.  Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.

Authors:  Hai-Bo Han; Jin Gu; Hui-Jing Zuo; Zhi-Guo Chen; Wei Zhao; Ming Li; Deng-Bo Ji; You-Yong Lu; Zhi-Qian Zhang
Journal:  J Pathol       Date:  2011-12-05       Impact factor: 7.996

5.  Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.

Authors:  Zhan Xiao; Zehan Chen; Angelo H Gunasekera; Thomas J Sowin; Saul H Rosenberg; Steve Fesik; Haiying Zhang
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

6.  Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors.

Authors:  Ping-Yu Wang; Yun-Xiao Sun; Shuai Zhang; Min Pang; Han-Han Zhang; Shu-Yan Gao; Can Zhang; Chang-Jun Lv; Shu-Yang Xie
Journal:  FEBS Lett       Date:  2013-07-11       Impact factor: 4.124

7.  Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.

Authors:  Xundi Xu; Hirofumi Yamamoto; Masato Sakon; Masayoshi Yasui; Chew Yee Ngan; Hiroki Fukunaga; Tetsushi Morita; Minoru Ogawa; Hiroaki Nagano; Shoji Nakamori; Mitsugu Sekimoto; Nariaki Matsuura; Morito Monden
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

8.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

Review 9.  MicroRNAs: novel regulators in the hallmarks of human cancer.

Authors:  Kai Ruan; Xiaoguang Fang; Gaoliang Ouyang
Journal:  Cancer Lett       Date:  2009-05-22       Impact factor: 8.679

10.  Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.

Authors:  Åslaug Helland; Michael S Anglesio; Joshy George; Prue A Cowin; Cameron N Johnstone; Colin M House; Karen E Sheppard; Dariush Etemadmoghadam; Nataliya Melnyk; Anil K Rustgi; Wayne A Phillips; Hilde Johnsen; Ruth Holm; Gunnar B Kristensen; Michael J Birrer; Richard B Pearson; Anne-Lise Børresen-Dale; David G Huntsman; Anna deFazio; Chad J Creighton; Gordon K Smyth; David D L Bowtell
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

View more
  3 in total

Review 1.  Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors.

Authors:  Pierre Autin; Christophe Blanquart; Delphine Fradin
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

2.  Let-7c-5p Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma.

Authors:  Yaxin Zheng; Mao Luo; Muhan Lü; Tiejun Zhou; Fang Liu; Xiaoni Guo; Jian Zhang; Min Kang
Journal:  Onco Targets Ther       Date:  2020-11-02       Impact factor: 4.147

Review 3.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.